Interpace Biosciences fully repays BroadOak term loan early, strengthens balance sheet

INTERPACE BIOSCIENCES, INC.

Fully repaid outstanding term loan facility with BroadOak Capital Partners prior to maturity.
Original Loan and Security Agreement dated October 29, 2021 with BroadOak Fund V, L.P.
Early repayment eliminates related interest expenses, increasing operational flexibility.
CFO Chris McCarthy says repayment reflects robust financial performance and disciplined capital management.
Company now focused on driving commercial growth and record testing volumes/revenue for thyroid tests.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.